Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 3
2008 5
2009 5
2010 1
2011 3
2012 5
2013 4
2014 13
2015 12
2016 10
2017 9
2018 20
2019 24
2020 24
2021 32
2022 36
2023 33
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis.
Fan S, Huo WX, Yang Y, Shen MZ, Mo XD. Fan S, et al. Front Immunol. 2022 Aug 4;13:954268. doi: 10.3389/fimmu.2022.954268. eCollection 2022. Front Immunol. 2022. PMID: 35990629 Free PMC article.
Ruxolitinib is an important treatment for steroid refractory graft-versus-host disease (SR-GVHD). Therefore, we reported the updated results of a systematic review and meta-analysis of ruxolitinib as treatment for SR-GVHD. ...
Ruxolitinib is an important treatment for steroid refractory graft-versus-host disease (SR-GVHD). Therefore, we …
Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders.
Arnold DD, Yalamanoglu A, Boyman O. Arnold DD, et al. Front Immunol. 2022 Jul 6;13:888392. doi: 10.3389/fimmu.2022.888392. eCollection 2022. Front Immunol. 2022. PMID: 35874710 Free PMC article.
RESULTS: Anakinra was both efficacious and safe in treating cryopyrin-associated periodic syndromes (CAPS), familial Mediterranean fever (FMF), gout, macrophage activation syndrome, recurrent pericarditis, rheumatoid arthritis (RA), and systemic juvenile idiopathic arthritis (sJI …
RESULTS: Anakinra was both efficacious and safe in treating cryopyrin-associated periodic syndromes (CAPS), familial Mediterranean fever (FM …
Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review.
Appeldoorn TYJ, Munnink THO, Morsink LM, Hooge MNL, Touw DJ. Appeldoorn TYJ, et al. Clin Pharmacokinet. 2023 Apr;62(4):559-571. doi: 10.1007/s40262-023-01225-7. Epub 2023 Mar 31. Clin Pharmacokinet. 2023. PMID: 37000342 Free PMC article.
Ruxolitinib is used to treat myelofibrosis, polycythemia vera and steroid-refractory graft-versus-host disease in the setting of allogeneic stem-cell transplantation. ...
Ruxolitinib is used to treat myelofibrosis, polycythemia vera and steroid-refractory graft-versus-host disease i …
Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations.
Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, Axéll T, Bruce AJ, Carpenter W, Eisenberg E, Epstein JB, Holmstrup P, Jontell M, Lozada-Nur F, Nair R, Silverman B, Thongprasom K, Thornhill M, Warnakulasuriya S, van der Waal I. Al-Hashimi I, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103 Suppl:S25.e1-12. doi: 10.1016/j.tripleo.2006.11.001. Epub 2007 Jan 29. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007. PMID: 17261375 Review.
These include lichenoid contact lesions, lichenoid drug reactions and lichenoid lesions of graft-versus-host disease. In regard to the approach to oral lichenoid contact lesions the value of patch testing remains controversial. Confirmation of the diag …
These include lichenoid contact lesions, lichenoid drug reactions and lichenoid lesions of graft-versus-host disease …
A systematic review of transfusion-associated graft-versus-host disease.
Kopolovic I, Ostro J, Tsubota H, Lin Y, Cserti-Gazdewich CM, Messner HA, Keir AK, DenHollander N, Dzik WS, Callum J. Kopolovic I, et al. Blood. 2015 Jul 16;126(3):406-14. doi: 10.1182/blood-2015-01-620872. Epub 2015 Apr 30. Blood. 2015. PMID: 25931584 Free article. Review.
Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare complication of blood transfusion. ...
Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare complication of blood transfusion. ...
Chronic graft-versus-recipient disease: Systematic review of joint and fascial involvement.
Hidalgo Calleja C, Sánchez González MD, Medina Luezas J, López Corral L. Hidalgo Calleja C, et al. Reumatol Clin (Engl Ed). 2023 May;19(5):235-243. doi: 10.1016/j.reumae.2023.04.001. Epub 2023 Apr 20. Reumatol Clin (Engl Ed). 2023. PMID: 37087381 Free article. Review.
BACKGROUND AND OBJECTIVE: Chronic graft-versus-host disease (cGVRD) is a systemic immune-mediated complication that occurs in approximately half of the patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HCT) and, although it …
BACKGROUND AND OBJECTIVE: Chronic graft-versus-host disease (cGVRD) is a systemic immune-mediated complication t …
Vedolizumab for acute gastrointestinal graft-versus-host disease: A systematic review and meta-analysis.
Li AC, Dong C, Tay ST, Ananthakrishnan A, Ma KS. Li AC, et al. Front Immunol. 2022 Nov 11;13:1025350. doi: 10.3389/fimmu.2022.1025350. eCollection 2022. Front Immunol. 2022. PMID: 36439135 Free PMC article.
OBJECTIVE: To determine the safety and efficacy of vedolizumab for the prophylaxis and treatment of gastrointestinal involvement of acute graft-versus-host disease (GVHD) (GI-aGVHD). METHODS: Literature search within PubMed, EMBASE, Web of Science, and …
OBJECTIVE: To determine the safety and efficacy of vedolizumab for the prophylaxis and treatment of gastrointestinal involvement of acute …
Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB, Flowers L, Huchko MJ, Long ME, MacLaughlin KL, Murphy J, Spiryda LB, Gold MA. Moscicki AB, et al. J Low Genit Tract Dis. 2019 Apr;23(2):87-101. doi: 10.1097/LGT.0000000000000468. J Low Genit Tract Dis. 2019. PMID: 30907775
Furthermore, history of cervical screening or previous hysterectomy was not included in registry study analysis, possibly leading to underestimation of CC incidence rates.Genital or chronic graft versus host disease is associated with an increase in hi …
Furthermore, history of cervical screening or previous hysterectomy was not included in registry study analysis, possibly leading to underes …
Graft-versus-host disease following liver transplantation: A systematic review of literature.
Kneifel F, Vogel T, Bormann E, Becker F, Houben P, Flammang I, Slepecka P, Eichelmann AK, Brockmann JG, Pascher A. Kneifel F, et al. Hepatol Commun. 2023 Sep 27;7(10):e0260. doi: 10.1097/HC9.0000000000000260. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37755878 Free PMC article.
BACKGROUND: Graft-versus-host disease following liver transplantation is a serious and usually fatal complication. ...Medical subject headings, such as graft-versus-host disease and GvHD were used in combination with solid o …
BACKGROUND: Graft-versus-host disease following liver transplantation is a serious and usually fatal complicatio …
Pruritus in cutaneous graft-versus-host disease: A systematic review.
Zhu J, Navarini AA, Halter JP, Mueller SM. Zhu J, et al. J Eur Acad Dermatol Venereol. 2023 Jul;37(7):1276-1283. doi: 10.1111/jdv.19057. Epub 2023 Apr 5. J Eur Acad Dermatol Venereol. 2023. PMID: 36950958 Review.
Pruritus is a common symptom of cutaneous graft-versus-host disease (GVHD) following haematopoietic stem cell transplantation (HSCT). ...
Pruritus is a common symptom of cutaneous graft-versus-host disease (GVHD) following haematopoietic stem cell tr …
211 results